Cellularline Future Growth
Future criteria checks 4/6
Cellularline is forecast to grow earnings and revenue by 24.1% and 7.4% per annum respectively.
Key information
24.1%
Earnings growth rate
n/a
EPS growth rate
Tech earnings growth | 93.7% |
Revenue growth rate | 7.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 14 Nov 2024 |
Recent future growth updates
Recent updates
Is Cellularline (BIT:CELL) Using Too Much Debt?
May 10Is Cellularline (BIT:CELL) A Risky Investment?
May 25At €4.58, Is Cellularline S.p.A. (BIT:CELL) Worth Looking At Closely?
Apr 29Some Investors May Be Worried About Cellularline's (BIT:CELL) Returns On Capital
Apr 04Do Institutions Own Cellularline S.p.A. (BIT:CELL) Shares?
Mar 14Does Cellularline's (BIT:CELL) Statutory Profit Adequately Reflect Its Underlying Profit?
Feb 21A Look At The Intrinsic Value Of Cellularline S.p.A. (BIT:CELL)
Feb 06Is There Now An Opportunity In Cellularline S.p.A. (BIT:CELL)?
Jan 21Should You Buy Cellularline S.p.A. (BIT:CELL) For Its Dividend?
Jan 06Reflecting on Cellularline's (BIT:CELL) Share Price Returns Over The Last Year
Dec 22How Much Of Cellularline S.p.A. (BIT:CELL) Do Insiders Own?
Dec 11Not Many Are Piling Into Cellularline S.p.A. (BIT:CELL) Just Yet
Nov 29Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 180 | 6 | 11 | 14 | 1 |
12/31/2024 | 167 | 5 | 15 | 19 | 1 |
9/30/2024 | 164 | 5 | 18 | 24 | N/A |
6/30/2024 | 163 | 6 | 19 | 24 | N/A |
3/31/2024 | 160 | 3 | 20 | 25 | N/A |
12/31/2023 | 159 | 4 | 8 | 13 | N/A |
9/30/2023 | 154 | -35 | 6 | 11 | N/A |
6/30/2023 | 151 | -36 | -1 | 3 | N/A |
3/31/2023 | 145 | -75 | 2 | 2 | N/A |
12/31/2022 | 138 | -75 | 0 | 5 | N/A |
9/30/2022 | 132 | -43 | 0 | 5 | N/A |
6/30/2022 | 125 | -44 | 1 | 7 | N/A |
3/31/2022 | 117 | -3 | 2 | 8 | N/A |
12/31/2021 | 111 | -4 | 14 | 19 | N/A |
9/30/2021 | 108 | 15 | 13 | 23 | N/A |
6/30/2021 | 108 | 15 | 17 | 27 | N/A |
3/31/2021 | 101 | 12 | 13 | 23 | N/A |
12/31/2020 | 105 | 14 | 1 | 11 | N/A |
9/30/2020 | 118 | 7 | 12 | 20 | N/A |
6/30/2020 | 122 | 12 | 13 | 19 | N/A |
3/31/2020 | 140 | 18 | 12 | 20 | N/A |
12/31/2019 | 140 | 18 | 12 | 20 | N/A |
9/30/2019 | 134 | 19 | 60 | 20 | N/A |
6/30/2019 | 136 | 22 | 115 | 34 | N/A |
3/31/2019 | 108 | 24 | 61 | 20 | N/A |
12/31/2018 | 94 | 32 | 11 | 13 | N/A |
9/30/2018 | 84 | 43 | N/A | N/A | N/A |
6/30/2018 | 152 | 37 | N/A | 1 | N/A |
3/31/2018 | 146 | 30 | N/A | 11 | N/A |
12/31/2017 | 139 | 24 | N/A | 21 | N/A |
12/31/2016 | 159 | 22 | N/A | 31 | N/A |
12/31/2015 | 157 | 9 | N/A | 21 | N/A |
12/31/2014 | 155 | 8 | N/A | 16 | N/A |
12/31/2013 | 0 | -1 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CELL's forecast earnings growth (24.1% per year) is above the savings rate (2.5%).
Earnings vs Market: CELL's earnings (24.1% per year) are forecast to grow faster than the Italian market (7.1% per year).
High Growth Earnings: CELL's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CELL's revenue (7.4% per year) is forecast to grow faster than the Italian market (4% per year).
High Growth Revenue: CELL's revenue (7.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CELL's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/18 07:21 |
End of Day Share Price | 2024/12/18 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cellularline S.p.A. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Andrea Bonfa | Banca Akros S.p.A. (ESN) |
Alberto Francese | Intesa Sanpaolo Equity Research |
Gabriele Berti | Intesa Sanpaolo Equity Research |